ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

4 links1 made here, not in the record6 judgments2 judges (the rules as one: Rule based)0 record changes seen
Claude Opus 5.5Rule basedMade here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT05390892PREvention ofCardIovascular and DiabEtickidNey Disease in Type 2DiabetesBrigham and Women's HospitalPhase 4 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSDiabetes Mellitus, Type 2No longer in the registry's filing›As of now · Rule based · Main conditionMain conditionDRUGSSGLT2 inhibitorsEntry “SGLT2 inhibitor”, read by our …›Nov 1 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedGLP-1 MimeticEntry “GLP-1 receptor agonist”, read …›Nov 1 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedSemaglutideMade here · Found by reading; no entr…›Nov 1 · Claude Opus 5.5 · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

SGLT2 inhibitors

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “SGLT2 inhibitor”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 1SGLT2 inhibitorsClaude Opus 5.5TestedCurrent
Nov 1GLP-1 MimeticClaude Opus 5.5TestedCurrent
Nov 1Semaglutidemade hereClaude Opus 5.5TestedCurrent
Nov 18SGLT2 inhibitorsRule based · role ruleTestedAgrees
Nov 18GLP-1 MimeticRule based · role ruleTestedAgrees
As of nowDiabetes Mellitus, Type 2Rule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.